| 注册
首页|期刊导航|化工进展|载阿霉素聚乳酸多孔微球的表征及释药性能

载阿霉素聚乳酸多孔微球的表征及释药性能

洪雅真 朱利会

化工进展2018,Vol.37Issue(3):1130-1136,7.
化工进展2018,Vol.37Issue(3):1130-1136,7.DOI:10.16085/j.issn.1000-6613.2017-1852

载阿霉素聚乳酸多孔微球的表征及释药性能

Synthesis,characterization and in vitro drug release performance of poly-L-lactide porous microspheres

洪雅真 1朱利会2

作者信息

  • 1. 华侨大学化工学院,福建 厦门 361021
  • 2. 华侨大学生物材料与组织工程研究所,福建 厦门 361021
  • 折叠

摘要

Abstract

Used the doxorubicin(DOX)as small molecule drug model,the DOX-loaded poly-L-lactide (PLLA)porous microspheres(PMs)were designed by adsorption method. The particle size distribution,aerodynamic properties,surface morphology,physical and chemical properties of PLLA PMs,and its successive drug-loaded conjugates,were detremined by various characterization techniques such as field emission-scanning electron microscope(FE-SEM),Fourier transform infrared spectrophotometry(FTIR),X-ray powder diffraction(XRPD)and differential scanning calorimetry (DSC),among others. Further,the drug loading,as well as encapsulation efficiencies and DOX-release performance in vitro,were also investigated. The PLLA PMs resulted in decreased encapsulation efficiencies(56%,51%,and 44%)with the increase in drug loading efficiencies(2.9%, 4.0% and 4.6%). DOX-loaded PLLA PMs exhibited sustained-release profiles,in which the effect lasted more than 5 days. These porous microspheres can be used as an efficient platform due to their excellent aerodynamic properties and sustained release effect,which will potentially play a significant role in pulmonary drug delivery.

关键词

阿霉素/多孔微球/聚乳酸/体外释放/肺部给药

Key words

doxorubicin/porous microspheres/poly-L-lactide/in vitro release/pulmonary drug delivery

分类

医药卫生

引用本文复制引用

洪雅真,朱利会..载阿霉素聚乳酸多孔微球的表征及释药性能[J].化工进展,2018,37(3):1130-1136,7.

化工进展

OA北大核心CSCDCSTPCD

1000-6613

访问量0
|
下载量0
段落导航相关论文